Compare Demedici Corporation vs Merck Patient Assistance Program Inc for a donation or grant decision: revenue, assets, mission score, CEO pay, red flags,…
| Metric | Demedici Corporation | Merck Patient Assistance Program Inc |
|---|---|---|
| EIN | 10818965 | 10575520 |
| State | NJ | NJ |
| City | Marlton | Rahway |
| NTEE Code | B112 | T210 |
| Revenue | $1.0M | $1.9B |
| Assets | $16.1M | $26.4M |
| Mission Score | 80/100 | 98/100 |
| Red Flags | 3 | 1 |
| Strengths | 4 | 5 |
Demedici Corporation: Demedici Corporation shows consistent revenue and asset growth with no reported officer compensation, but liabilities have significantly increased.
Merck Patient Assistance Program Inc: Merck Patient Assistance Program consistently disburses 100% of its nearly $2 billion annual revenue directly to programs.
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.